counter easy hit

Thursday, 18 October 2018

Book Improvement in Verbal Memory Following SSRI Augmentation of Antipsychotic Treatment is Associated with Changes in the Expression of MRNA Encoding for the GABA-A Receptor and BDNF in PMC of Schizophrenic Patients PDF Free

Improvement in Verbal Memory Following SSRI Augmentation of Antipsychotic Treatment is Associated with Changes in the Expression of MRNA Encoding for the GABA-A Receptor and BDNF in PMC of Schizophrenic Patients PDF
By:
Published on 2015 by


Abstract : Verbal memory impairment in schizophrenia is associated with abnormalities in gamma-aminobutyric acid (GABA)-ergic and brain-derived neurotrophic factor (BDNF) systems. Recent evidence from animal and clinical studies that adding fluvoxamine to antipsychotics alters the expression of transcripts encoding for the GABA-A receptor and BDNF led us to postulate that fluvoxamine augmentation may improve memory in schizophrenia. To test this, we examined the effect of add-on fluvoxamine on verbal memory and other cognitive functions and related it to the expression of mRNA coding for the GABA-A receptor and BDNF in peripheral mononuclear cells (PMC) of schizophrenic patients. Twenty-nine patients completed a 6-week study in which fluvoxamine (100 mg/day) was added to ongoing antipsychotic treatment. Verbal memory, abstraction working memory, object and face recognition, and psychomotor speed and clinical symptoms were assessed at baseline and after 3 and 6 weeks of treatment. Blood samples were taken at baseline and weeks 1, 3, and 6 and PMC was assayed for the GABA-A beta3 receptor and BDNF mRNA by quantitative real-time reverse transcription-PCR. Associative and logical verbal memory improved significantly and showed a significant correlation with changes in PMC BDNF and GABA-A beta3 receptor mRNA, which increased during treatment. Abstraction and object recognition improved, but this did not correlate with PMC measures. Negative and positive symptoms improved significantly; the latter showed significant correlations with changes in PMC measures. Addition of fluvoxamine to antipsychotics improves verbal memory. It is postulated that the mechanism involves enhanced GABA-A receptor/BDNF-dependent synaptic plasticity in the hippocampus.

This Book was ranked at 38 by Google Books for keyword Memory Improvement.

Book ID of Improvement in Verbal Memory Following SSRI Augmentation of Antipsychotic Treatment is Associated with Changes in the Expression of MRNA Encoding for the GABA-A Receptor and BDNF in PMC of Schizophrenic Patients's Books is UbeFswEACAAJ, Book which was written by have ETAG "da5uAYOezBs"

Book which was published by since 2015 have ISBNs, ISBN 13 Code is and ISBN 10 Code is

Reading Mode in Text Status is false and Reading Mode in Image Status is false

Book which have " Pages" is Printed at BOOK under Category

Book was written in en

eBook Version Availability Status at PDF is falseand in ePub is false

Book Preview


Download Improvement in Verbal Memory Following SSRI Augmentation of Antipsychotic Treatment is Associated with Changes in the Expression of MRNA Encoding for the GABA-A Receptor and BDNF in PMC of Schizophrenic Patients PDF Free

Download Improvement in Verbal Memory Following SSRI Augmentation of Antipsychotic Treatment is Associated with Changes in the Expression of MRNA Encoding for the GABA-A Receptor and BDNF in PMC of Schizophrenic Patients Books Free

Download Improvement in Verbal Memory Following SSRI Augmentation of Antipsychotic Treatment is Associated with Changes in the Expression of MRNA Encoding for the GABA-A Receptor and BDNF in PMC of Schizophrenic Patients Free

Download Improvement in Verbal Memory Following SSRI Augmentation of Antipsychotic Treatment is Associated with Changes in the Expression of MRNA Encoding for the GABA-A Receptor and BDNF in PMC of Schizophrenic Patients PDF

Download Improvement in Verbal Memory Following SSRI Augmentation of Antipsychotic Treatment is Associated with Changes in the Expression of MRNA Encoding for the GABA-A Receptor and BDNF in PMC of Schizophrenic Patients Books

No comments:

Post a Comment